# Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening

> **NCT07631624** · NA · RECRUITING · sponsor: **University Hospital, Antwerp** · enrollment: 1000 (estimated)

## Conditions studied

- Epigenetics
- DNA Methylation
- Lung Cancer Screening
- Risk Stratification With Biomarker
- Saliva

## Interventions

- **GENETIC:** DNA-methylation in saliva

## Key facts

- **NCT ID:** NCT07631624
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-04
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631624, "Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07631624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*